{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:51:07Z","timestamp":1757703067319},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.amjcard.2006.02.036","type":"journal-article","created":{"date-parts":[[2006,6,13]],"date-time":"2006-06-13T14:20:58Z","timestamp":1150208458000},"page":"325-330","source":"Crossref","is-referenced-by-count":9,"title":["Relation of Preprocedural Statin Therapy to In-Hospital Procedural Complications Following Percutaneous Coronary Interventions in Patients With Hyperlipidemia"],"prefix":"10.1016","volume":"98","author":[{"given":"Mandeep","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique L.","family":"Roger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charanjit S.","family":"Rihal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Halligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"David R.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2006.02.036_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0735-1097(02)01980-0","article-title":"Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention","volume":"40","author":"Singh","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.036_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0002-9149(01)01576-4","article-title":"Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention","volume":"88","author":"Resnic","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.036_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.CIR.104.3.263","article-title":"Simple bedside additive tool for prediction of in-hospital mortality after percutaneous coronary interventions","volume":"104","author":"Moscucci","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.02.036_bib4","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0735-1097(95)00294-4","article-title":"Development and validation of simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice","volume":"26","author":"Kimmel","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.036_bib5","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/01.CIR.95.11.2479","article-title":"Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes","volume":"95","author":"Ellis","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.02.036_bib6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0735-1097(02)01731-X","article-title":"Development of a risk adjustment mortality model using the American College of Cardiology\u2013National Cardiovascular Data Registry (ACC-NCDR) experience","volume":"39","author":"Shaw","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.036_bib7","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0735-1097(01)01344-4","volume":"37","author":"Smith","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.036_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0735-1097(98)00208-3","article-title":"Identification of variables needed to risk adjust outcomes of coronary interventions","volume":"32","author":"Block","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.036_bib9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/hc0602.103586","article-title":"Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention","volume":"105","author":"Chan","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.02.036_bib10","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1161\/01.CIR.0000060541.18923.E9","article-title":"Relation of inflammation and benefit of statins after percutaneous coronary interventions","volume":"107","author":"Chan","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.02.036_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ccd.20078","article-title":"Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome","volume":"62","author":"Chang","year":"2004","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2006.02.036_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9149(01)02153-1","article-title":"Benefits of immediate initiation of statin therapy following successful coronary stent implantation in patients with stable and unstable angina pectoris and Q-wave acute myocardial infarction","volume":"89","author":"Walter","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.036_bib13","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.02.036_bib14","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.amjcard.2004.07.140","article-title":"Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury","volume":"94","author":"Mulukutla","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.036_bib15","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/01.CIR.0000028146.71416.2E","article-title":"Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy","volume":"106","author":"Ellis","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.02.036_bib16","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.82.4.1193","article-title":"Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection","volume":"82","author":"Ellis","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.02.036_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0735-1097(99)00267-3","article-title":"Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994\u20131996","volume":"34","author":"O\u2019Connor","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.036_bib18","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.jacc.2003.06.014","article-title":"Simplified scoring system for predicting mortality after percutaneous coronary intervention","volume":"42","author":"Qureshi","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2006.02.036_bib19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1365-2389.2003.51313.x","article-title":"Low total cholesterol and increased risk of dying","volume":"51","author":"Brescianini","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjcard.2006.02.036_bib20","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(00)04257-4","article-title":"Effect of lipid-lowering therapy on early mortality after acute coronary syndromes","volume":"357","author":"Aronow","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2006.02.036_bib21","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2006.02.036_bib22","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1053\/euhj.1999.1987","article-title":"Plasma levels of C-reactive protein after coronary stent implantation","volume":"21","author":"Gottsauner-Wolf","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2006.02.036_bib23","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease","volume":"343","author":"Lindahl","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2006.02.036_bib24","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/01.CIR.102.16.1917","article-title":"Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease","volume":"102","author":"Muhlestein","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2006.02.036_bib25","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0735-1097(00)00950-5","article-title":"Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease","volume":"36","author":"Horne","year":"2000","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906007156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914906007156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T20:59:36Z","timestamp":1547585976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914906007156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0002914906007156"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2006.02.036","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}